European Radiology

, Volume 23, Issue 4, pp 1044–1049 | Cite as

Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients

  • Hyun Kyung Lim
  • Jeong Hyun Lee
  • Eun Ju Ha
  • Jin Young Sung
  • Jae Kyun Kim
  • Jung Hwan BaekEmail author
Head and Neck



To evaluate the clinical outcomes and safety of radiofrequency (RF) ablation for benign non-functioning thyroid nodules over a 4-year follow-up.


We evaluated 126 benign non-functioning thyroid nodules of 111 patients treated with RF ablation and followed-up more than 3 years. RF ablation was performed using the Cool-Tip RF system and an internally cooled electrode. Nodule volume and cosmetic and symptom scores were evaluated before treatment and during follow-up. Complications and factors related to efficacy were evaluated.


The mean follow-up duration was 49.4 ± 13.6 months. Thyroid nodule volume decreased significantly, from 9.8 ± 8.5 ml before ablation to 0.9 ± 3.3 ml (P < 0.001) at final evaluation: a mean volume reduction of 93.4 ± 11.7 %. The mean cosmetic (P < 0.001) and symptom scores (P < 0.001) improved significantly. Factors related to efficacy were initial solidity and volume. The overall recurrence rate was 5.6 % (7/126). The overall complication rate was 3.6 % (4/111).


RF ablation was effective in shrinking benign thyroid nodules and in controlling nodule-related problems over a 4-year follow-up. There were no life-threatening complications or sequelae. Therefore, RF ablation can be used as a non-surgical treatment for patients with benign non-functioning thyroid nodules.

Key Points

• Radiofrequency (RF) ablation provides a non-surgical option for benign non-functioning thyroid nodules

• RF ablation reduced non-functioning thyroid nodular volume by 93.5 % after 49 months

• Initial solidity and volume influenced the efficacy of RF ablation

• Larger thyroid nodules required more treatment sessions to achieve appropriate volume reduction

• Complete treatment of the periphery of the nodule is important in preventing marginal regrowth


Radiofrequency ablation Thyroid nodules Ultrasound Laser ablation Ethanol ablation 





Ethanol ablation


Laser ablation




Fine-needle aspiration biopsy



We declare that we have no proprietary, commercial or financial interests that could be construed to have inappropriately influenced this study. Of the 111 patients, 91 participated in previously published study by Jeong et al. [14], 7 in the study by Baek et al. [17], and 13 in the study by Sung et al. [4].


  1. 1.
    Hegedus L (2009) Therapy: a new nonsurgical therapy option for benign thyroid nodules? Nat Rev Endocrinol 5:476–478PubMedCrossRefGoogle Scholar
  2. 2.
    Del Prete S, Caraglia M, Russo D et al (2002) Percutaneous ethanol injection efficacy in the treatment of large symptomatic thyroid cystic nodules: ten-year follow-up of a large series. Thyroid 12:815–821PubMedCrossRefGoogle Scholar
  3. 3.
    Guglielmi R, Pacella CM, Bianchini A et al (2004) Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid 14:125–131PubMedCrossRefGoogle Scholar
  4. 4.
    Sung JY, Kim YS, Choi H, Lee JH, Baek JH (2011) Optimum first-line treatment technique for benign cystic thyroid nodules: ethanol ablation or radiofrequency ablation? AJR Am J Roentgenol 196:W210–214PubMedCrossRefGoogle Scholar
  5. 5.
    Kim JH, Lee HK, Lee JH, Ahn IM, Choi CG (2003) Efficacy of sonographically guided percutaneous ethanol injection for treatment of thyroid cysts versus solid thyroid nodules. AJR Am J Roentgenol 180:1723–1726PubMedCrossRefGoogle Scholar
  6. 6.
    Lee JH, Kim YS, Lee D, Choi H, Yoo H, Baek JH (2010) Radiofrequency ablation (RFA) of benign thyroid nodules in patients with incompletely resolved clinical problems after ethanol ablation (EA). World J Surg 34:1488–1493PubMedCrossRefGoogle Scholar
  7. 7.
    Pacella CM, Bizzarri G, Guglielmi R et al (2000) Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology 217:673–677PubMedGoogle Scholar
  8. 8.
    Døssing H, Bennedbaek FN, Karstrup S, Hegedus L (2002) Benign solitary solid cold thyroid nodules: US-guided interstitial laser photocoagulation–initial experience. Radiology 225:53–57PubMedCrossRefGoogle Scholar
  9. 9.
    Valcavi R, Riganti F, Bertani A, Formisano D, Pacella CM (2010) Percutaneous laser ablation of cold benign thyroid nodules: a 3-year follow-up study in 122 patients. Thyroid 20:1253–1261PubMedCrossRefGoogle Scholar
  10. 10.
    Døssing H, Bennedbæk FN, Hegedus L (2011) Long-term outcome following interstitial laser photocoagulation of benign cold thyroid nodules. Eur J Endocrinol 165:123–128PubMedCrossRefGoogle Scholar
  11. 11.
    Baek JH, Moon WJ, Kim YS, Lee JH, Lee D (2009) Radiofrequency ablation for the treatment of autonomously functioning thyroid nodules. World J Surg 33:1971–1977PubMedCrossRefGoogle Scholar
  12. 12.
    Baek JH, Jeong HJ, Kim YS, Kwak MS, Lee D (2008) Radiofrequency ablation for an autonomously functioning thyroid nodule. Thyroid 18:675–676PubMedCrossRefGoogle Scholar
  13. 13.
    Deandrea M, Limone P, Basso E et al (2008) US-guided percutaneous radiofrequency thermal ablation for the treatment of solid benign hyperfunctioning or compressive thyroid nodules. Ultrasound Med Biol 34:784–791PubMedCrossRefGoogle Scholar
  14. 14.
    Jeong WK, Baek JH, Rhim H et al (2008) Radiofrequency ablation of benign thyroid nodules: safety and imaging follow-up in 236 patients. Eur Radiol 18:1244–1250PubMedCrossRefGoogle Scholar
  15. 15.
    Kim YS, Rhim H, Tae K, Park DW, Kim ST (2006) Radiofrequency ablation of benign cold thyroid nodules: initial clinical experience. Thyroid 16:361–367PubMedCrossRefGoogle Scholar
  16. 16.
    Spiezia S, Garberoglio R, Milone F et al (2009) Thyroid nodules and related symptoms are stably controlled two years after radiofrequency thermal ablation. Thyroid 19:219–225PubMedCrossRefGoogle Scholar
  17. 17.
    Baek JH, Kim YS, Lee D, Huh JY, Lee JH (2010) Benign predominantly solid thyroid nodules: prospective study of efficacy of sonographically guided radiofrequency ablation versus control condition. AJR Am J Roentgenol 194:1137–1142PubMedCrossRefGoogle Scholar
  18. 18.
    Jang SW, Baek JH, Kim JK et al (2012) How to manage the patients with unsatisfactory results after ethanol ablation for thyroid nodules: Role of radiofrequency ablation. Eur J Radiol 81:905–910PubMedCrossRefGoogle Scholar
  19. 19.
    Moon WJ, Baek JH, Jung SL et al (2011) Ultrasonography and the ultrasound-based management of thyroid nodules: consensus statement and recommendations. Korean J Radiol 12:1–14PubMedCrossRefGoogle Scholar
  20. 20.
    Moon WJ, Jung SL, Lee JH et al (2008) Benign and malignant thyroid nodules: US differentiation–multicenter retrospective study. Radiology 247:762–770PubMedCrossRefGoogle Scholar
  21. 21.
    Kim YJ, Baek JH, Ha EJ et al (2012) Cystic versus predominantly cystic thyroid nodules: efficacy of ethanol ablation and analysis of related factors. Eur Radiol 22:1573–1578PubMedCrossRefGoogle Scholar
  22. 22.
    Baek JH, Lee JH, Valcavi R, Pacella CM, Rhim H, Na DG (2011) Thermal ablation for benign thyroid nodules: radiofrequency and laser. Korean J Radiol 12:525–54023PubMedCrossRefGoogle Scholar
  23. 23.
    Ha EJ, Baek JH, Lee JH, Kim JK, Shong YK (2011) Clinical significance of vagus nerve variation in radiofrequency ablation of thyroid nodules. Eur Radiol 21:2151–2157PubMedCrossRefGoogle Scholar
  24. 24.
    Spiezia S, Garberoglio R, Di Somma C et al (2007) Efficacy and safety of radiofrequency thermalablation in the treatment of thyroid nodules with pressure symptoms in elderly patients. J Am Geriatr Soc 55:1478–1479PubMedCrossRefGoogle Scholar
  25. 25.
    Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRefGoogle Scholar
  26. 26.
    Goldberg SN, Charboneau JW, Dodd GD et al (2003) Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228:335–345PubMedCrossRefGoogle Scholar
  27. 27.
    Sacks D, McClenny TE, Cardella JF, Lewis CA (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–202PubMedCrossRefGoogle Scholar
  28. 28.
    Ha EJ, Baek JH, Lee JH (2011) The efficacy and complications of radiofrequency ablation of thyroid nodules. Curr Opin Endocrinol Diabetes Obes 18:310–314PubMedGoogle Scholar
  29. 29.
    Spiezia S, Vitale G, Di Somma C et al (2003) Ultrasound-guided laser thermal ablation in the treatment of autonomous hyperfunctioning thyroid nodules and compressive nontoxic nodular goiter. Thyroid 13:941–947PubMedCrossRefGoogle Scholar

Copyright information

© European Society of Radiology 2012

Authors and Affiliations

  • Hyun Kyung Lim
    • 2
  • Jeong Hyun Lee
    • 2
  • Eun Ju Ha
    • 2
  • Jin Young Sung
    • 1
  • Jae Kyun Kim
    • 3
  • Jung Hwan Baek
    • 1
    • 2
    Email author
  1. 1.Department of Radiology, Thyroid CenterDaerim St. Mary’s HospitalSeoulKorea
  2. 2.Department of Radiology and Research Institute of Radiology, Asan Medical CenterUniversity of Ulsan College of MedicineSeoulKorea
  3. 3.Department of RadiologyChung-Ang University HospitalSeoulKorea

Personalised recommendations